These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 34755033)

  • 1. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
    Ellen Kuenzig M; Windsor JW; Barrett L; Bernstein CN; Bitton A; Carroll MW; Chauhan U; Coward S; Fowler S; Ghia JE; Geist R; Gibson DL; Graff LA; Griffiths AM; Guoxian Huang J; Jones JL; Khanna R; Lakatos PL; Lee K; Mack DR; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Panaccione R; Seow CH; Singh H; Tandon P; Targownik LE; Zelinsky S; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S1-S9. PubMed ID: 34755033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
    Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
    Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life.
    Graff LA; Fowler S; Jones JL; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Targownik LE; Windsor JW; Bernstein CN
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S46-S53. PubMed ID: 34755039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
    Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations.
    Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary.
    Windsor JW; Kuenzig ME; Murthy SK; Bitton A; Bernstein CN; Jones JL; Lee K; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Davis T; Weinstein J; Goddard Q; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S1-S8. PubMed ID: 37674500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over Time.
    Coward S; Windsor JW; Kuenzig ME; Bitton A; Bernstein CN; Jones JL; Khanna R; Lee K; Murthy SK; Targownik L; Benchimol E; Huang JG; Mukhtar MS; Tandon P; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S20-S26. PubMed ID: 34755035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
    Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.
    Kaplan GG; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Ghandeharian S; Rohatinsky N; Weinstein J; Jones May T; Browne M; Jannati N; Tabatabavakili S; Im JHB; Meka S; Vukovic S; Davis T; Goddard Q; Gorospe J; Stocks T; Caplan L; Kanaan N; Stuart D; Ramsay T; Robinson KJ; Charron-Bishop D; Benchimol EI
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S76-S82. PubMed ID: 37674494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications.
    Targownik LE; Bernstein CN; Lakatos PL; Murthy SK; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Jones JL; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Windsor JW; Panaccione R
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S40-S45. PubMed ID: 34755038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care.
    Jones JL; Benchimol EI; Bernstein CN; Huang JG; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Kaplan GG; Kuenzig ME; Tandon P; Targownik LE; Windsor JW; Bitton A
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S61-S67. PubMed ID: 34755041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
    Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.
    Benchimol EI; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Siddiq S; Windsor JW; Carroll MW; Coward S; El-Matary W; Griffiths AM; Jones JL; Kuenzig ME; Lee L; Mack DR; Mawani M; Otley AR; Singh H; Targownik LE; Weizman AV; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S1-S5. PubMed ID: 31294380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
    Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
    Front Immunol; 2022; 13():933774. PubMed ID: 35812420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD.
    Coward S; Benchimol EI; Kuenzig ME; Windsor JW; Bernstein CN; Bitton A; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Davis T; Weinstein J; Goddard Q; Bennett J; Caplan L; Bergevin M; Yang XY; Mason K; Sanderson R; Brass C; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S9-S15. PubMed ID: 37674492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
    Tepasse PR; Vollenberg R; Nowacki TM
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.